Duovir 150 mg/300 mg (Lamivudine/Zidovudine) Quantity:180 Tablet/s the combination therapy delays the

the combination therapy delays the onset of motor complications

decreasing systemic vascular resistance and lowering arterial pressure

Mahagra is contraindicated in patients using nitrate medications due to risk of severe hypotension

Genital yeast infections

Assurans 20mg does not increase sexual desire

Duovir 150 mg/300 mg (Lamivudine/Zidovudine) Quantity:180 Tablet/s the combination therapy delays theProduct Overview Duovir 150 mg 300 mg is a fixeddose combination tablet manufactured by Cipla Limited, a globally recognised pharmaceutical company. Each bottle contains 60 filmcoated tablets that deliver 150 mg of lamivudine and 300 mg of zidovudine, two nucleoside reverse transcriptase inhibitors (NRTIs) formulated for the treatment of HIV1 infection in adults. The product is supplied in a sealed, tamperevident bottle to preserve potency and protect